(a) Definitions
For purposes of this Rule, the following terms shall be defined as provided.
(1) "Emerging Growth Company" has the same meaning as in Section 3(a)(80) of the Exchange Act.
(2) "Equity security" has the same meaning as defined in Section 3(a)(11) of the Exchange Act.
(3) "Independent third-party research report" means a third-party research report
SEC Approves Rule to Establish an Accounting Support Fee to Fund the Governmental Accounting Standards Board
GUIDANCE
Corporate Debt Securities
SUGGESTED ROUTING
KEY TOPICS
Corporate Finance
Legal and Compliance
Operations
Senior Management
Technology
Trading and Market Making
Training
Credit Default Swaps
Debt Securities
Operations
Options
Rule 6200 Series
TRACE Rules
Transaction Reporting
Executive Summary
NASD provides interpretive guidance under Rule 6230 on the
obligation of
Hello, In regards to the Regulatory Notice issued by the Financial Industry Regulatory Authority (FINRA) on March 8, 2022, I would like to express my concern as to the potential limits this rule will impose on some investors for buying and selling of the leveraged and inverse funds or other products deemed to be complex in nature. I regularly use these products as a focal point of my trading
I am deeply disturbed by the proposed regulation limiting access to leveraged and inverse ETFs (which are publicly-traded securities) to those with high net worth who pass a specialized regulatory exam and then jump through a series of administrative and timing-related hoops.
Leveraged and inverse ETFs are one of the few methods that the little guy has in order to protect his or her investments
I am extremely disappointed to hear about yet another regulation to come from this already overreaching authority. I am an individual investor and these leveraged products have played an important role in my portfolio for over a decade. I have used them to both limit my risk and to enhance returns. As an example, I wanted exposure to the S&P 500 but also wanted to hedge a portion of
I appreciate FINRAs concern regarding complex products. In this case, I think it is entirely inappropriate to place any restrictions them buying these types of products, but warnings would be helpful. I believe this for a number of reasons:
1.Restrictions hurt investors by taking away options. For me in particular, restricting access to purchase these products may ruin 10 years of work and a
I strongly support FINRA's mission to protect investors from ensuring an open, honest, and fair securities market, a key piece of which is striving to align investor needs and goals with product choice. It is probably or even likely that "complex" products are not appropriate for most investors, and to that end these products are broadly not used by most investors. Few defined
SUGGESTED ROUTING:*
Senior ManagementInstitutionalLegal & ComplianceMunicipalOperationsSystemsTrading*These are suggested departments only. Others may be appropriate for your firm.
EXECUTIVE SUMMARY
On November 9, 1992, the NASD® submitted rule proposals to the Securities and Exchange Commission (SEC) regarding quotation and transaction reporting requirements for members trading
Merger of FINRA Dispute Resolution
Regulatory Notice
Notice Type
Rule Amendment
Referenced Rules & Notices
By-Laws of FINRA Dispute Resolution, Inc.
By-Laws of FINRA Regulation, Inc.
Plan of Allocation and Delegation of Functions by NASD to Subsidiaries
Suggested Routing
